| Print
Viatris (VTRS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Address
1000 Mylan Boulevard
Canonsburg
PA
USA
15317
Telephone
+1 724 5141813
Forecast key dates
| Name | Key Date |
|---|---|
| Viatris Inc Fourth Quarter Earnings Conference Call for 2026 | 2027-02-26T08:30:00 |
| Viatris Inc Fourth Quarter Earnings Results for 2026 | 2027-02-26T00:00:00 |
| Viatris Inc Annual General Meeting for 2026 | 2026-12-04T11:00:00 |
| Viatris Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T08:30:00 |
| Viatris Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| Viatris Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-07T08:30:00 |
| Viatris Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| Viatris Inc First Quarter Earnings Conference Call for 2026 | 2026-05-08T08:30:00 |
| Viatris Inc First Quarter Earnings Results for 2026 | 2026-05-08T00:00:00 |
| Viatris Investor Event | 2026-03-19T00:00:00 |
| Viatris Inc Annual Report for 2025 | 2026-02-27T00:00:00 |
| Viatris Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-26T08:30:00 |
| Viatris Inc Fourth Quarter Earnings Results for 2025 | 2026-02-26T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.